BREAST CANCER RADIOGRAPHIC OR ECHOGRAPHIC CHANGES
Kholmahmat Musurmon Akmal Aktamovich Rakhila Botirboy kizi
ugli Uralov Normamatov Gafurova
Clinical interns at the Department of Medical Radiation Diagnostics Samarkand State
Medical Institute
ABSTRACT
Compared with other fields of medicine, there is hardly an area that has seen such fast development as the world of breast cancer. Indeed, the way we treat breast cancer has changed fundamentally over the past decades. Breast imaging has always been an integral part of this change, and it undergoes constant adjustment to new ways of thinking. This relates not only to the technical tools we use for diagnosing breast cancer but also to the way diagnostic information is used to guide treatment. There is a constant change of concepts for and attitudes toward breast cancer, and a constant flux of new ideas, new treatment approaches, and new insights into the molecular and biological behavior of this disease
Keywords: breast cancer, mammography, breast ultrasound, breast MRI
INTRODUCTION
Diagnostic or treatment approaches that are considered useful today may be abandoned tomorrow. Approaches that seem irrelevant or far too extravagant today may prove clinically useful and adequate next year. Radiologists must constantly question what they do, and align their clinical aims and research objectives with the changing needs of contemporary breast oncology. Moreover, knowledge about the past helps better understand present debates and controversies. Accordingly, in this article, we provide an overview on the evolution of breast imaging and breast cancer treatment, describe current areas of research, and offer an outlook regarding the years to come. Nowadays, breast imaging rocks.
METHODOLOGY
Compared with other fields of medicine, or other sectors in the field of imaging, there is hardly an area that has seen such fast development over the past decades. This relates not only to the technical tools we use for our clinical task of diagnosing disease that requires treatment. Indeed, the way we treat breast cancer has changed constantly and fundamentally over the past decades. Breast imaging has always been an integral part of this change, and it undergoes constant adjustment to new ways of thinking. Breast cancer is now usually small and node-negative at the time of diagnosis, and
women are treated by a multi-disciplinary team of experts who all strive to make her not only survive, but to also keep her female integrity. If diagnosed early, breast cancer now represents a highly curable disease.
DISCUSSION
Breast imaging is special. Nowhere else, possibly with the sole exception of dedicated interventional radiology, is the radiologist as visible as in the breast imaging arena. Here, the radiologist is integrated in a multidisciplinary team, where he or she is recognized as a physician who assumes direct and personal patient responsibility and genuinely cares for patients. The radiologist may accompany a woman for many years for screening. When signs or symptoms of breast cancer arise, or in case a screening abnormality is found, the radiologist will be the first to discuss these findings with the patient and her family. It is usually the radiologist alone who decides whether biopsy is needed or not. He or she will then do the biopsy and discuss the pathology results with the patient, her family, and other health care providers. The radiologist is experienced in communicating to a patient and her family that breast cancer is present, and knows how to respond to sorrow and anxieties. The radiologist will then, often enough, be asked to help find a breast surgeon for the patient and will thus become a referring physician for other disciplines.
RESULT
Breast imaging was the first specialty in the field of imaging, where standardized wording, and then standardized reporting, was developed to ensure that our messages are clear and unambiguously taken.1 Breast radiologists were first to systematically communicate factors that would interfere with a correct diagnosis, such as breast density or background enhancement. On pathophysiological grounds, overdiagnosis, but also underdiagnosis, of breast cancer due to mammographic screening is plausible. Radiographic breast imaging (digital mammography, but also digital breast tomosynthesis) is based mainly on the depiction of regressive changes. Mammographic hallmarks of breast cancer are architectural distortions, spiculated masses, and calcifications. This reflects pathophysiological changes such as fibrosis and necrosis, in other words effects that are caused by cancer hypoxia and that lead to slowed growth and cell death.
CONCLUSION
Even before the discussion around overdiagnosis, it was well established that mammography preferably detects slowly growing cancers. Cancers detected through mammographic screening are known to enjoy a better prognosis than cancers of the
same size and stage that were not diagnosable through mammography, an effect known as "length time bias".Overdiagnosis is a length time bias put to extreme. On the other hand, if a cancer is successful in maintaining its need for perfusion, it will not develop necrosis or calcifications and will not cause architectural distortions. Biologically important breast cancers are therefore frequently occult on mammography and, if they are detectable on mammography or ultrasound, may mimic fibroadenomas or even cysts.
REFERENCES
1. American College of Radiology (ACR) ACR BI-RADS—mammography; ultrasound; magnetic resonance imaging. In: ACR Breast Imaging Reporting and Data System, Breast Imaging Atlas. 2nd ed Reston, VA: American College of Radiology; 2015.
2. Ikeda DM, Hylton NM, Kinkel K, et al. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging. 2001
3. Kim SJ, Morris EA, Liberman L, et al. Observer variability and applicability of BIRADS terminology for breast MR imaging: invasive carcinomas as focal masses. AJR Am J Roentgenol. 2001;
4. Lehman CD, Blume JD, Thickman D, et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol. 2005
5. Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol. 2005